NO873571L - Fremgangsmaate for fremstilling av et terapeutisk virksomtpreparat. - Google Patents

Fremgangsmaate for fremstilling av et terapeutisk virksomtpreparat.

Info

Publication number
NO873571L
NO873571L NO873571A NO873571A NO873571L NO 873571 L NO873571 L NO 873571L NO 873571 A NO873571 A NO 873571A NO 873571 A NO873571 A NO 873571A NO 873571 L NO873571 L NO 873571L
Authority
NO
Norway
Prior art keywords
preparation
procedure
operating company
therapeutic operating
therapeutic
Prior art date
Application number
NO873571A
Other languages
English (en)
Norwegian (no)
Other versions
NO873571D0 (no
Inventor
Yukifumi Noda
Hiroyuki Nabata
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of NO873571D0 publication Critical patent/NO873571D0/no
Publication of NO873571L publication Critical patent/NO873571L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO873571A 1986-08-27 1987-08-24 Fremgangsmaate for fremstilling av et terapeutisk virksomtpreparat. NO873571L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19879686 1986-08-27

Publications (2)

Publication Number Publication Date
NO873571D0 NO873571D0 (no) 1987-08-24
NO873571L true NO873571L (no) 1988-02-29

Family

ID=16397046

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873571A NO873571L (no) 1986-08-27 1987-08-24 Fremgangsmaate for fremstilling av et terapeutisk virksomtpreparat.

Country Status (22)

Country Link
US (1) US4870090A (ja)
JP (1) JPH07121863B2 (ja)
KR (1) KR950002151B1 (ja)
AU (1) AU603375B2 (ja)
BE (1) BE1003959A5 (ja)
CA (1) CA1302888C (ja)
CH (1) CH672069A5 (ja)
DE (1) DE3728499A1 (ja)
DK (1) DK171392B1 (ja)
FI (1) FI873727A (ja)
FR (1) FR2605222B1 (ja)
GB (1) GB2195532B (ja)
HK (1) HK64993A (ja)
IE (1) IE60601B1 (ja)
IT (1) IT1211477B (ja)
LU (1) LU86973A1 (ja)
NL (1) NL8701994A (ja)
NO (1) NO873571L (ja)
NZ (1) NZ221564A (ja)
SE (1) SE502323C2 (ja)
SG (1) SG52393G (ja)
ZA (1) ZA876401B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736529A (en) * 1996-03-22 1998-04-07 Neurocal International Inc. Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration
US6329349B1 (en) * 1997-10-23 2001-12-11 Trustees Of The University Of Pennsylvania Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents
US6417207B1 (en) 1999-05-12 2002-07-09 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
CN107773545A (zh) * 2016-08-29 2018-03-09 烟台益诺依生物医药科技有限公司 依达拉奉与(+)‑2‑莰醇的舌下用药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
GB1562962A (en) * 1976-04-02 1980-03-19 Chugai Pharmaceutical Co Ltd Nicotinamide derivatives processes for producting the same and pharmaceutical compositions containing the same
EP0223811A1 (en) * 1985-05-22 1987-06-03 Beecham Group Plc Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
US4696934A (en) * 1986-01-10 1987-09-29 Warner-Lambert Company Method for using nifedipine for treating stroke
WO1987005508A1 (en) * 1986-03-14 1987-09-24 Medical College Of Wisconsin Research Foundation, Method of treatment and prevention of cerebral vasospasms

Also Published As

Publication number Publication date
ZA876401B (en) 1988-04-27
JPH07121863B2 (ja) 1995-12-25
CA1302888C (en) 1992-06-09
BE1003959A5 (fr) 1992-07-22
FR2605222B1 (fr) 1991-02-22
KR880002525A (ko) 1988-05-09
NZ221564A (en) 1999-08-30
IE872218L (en) 1988-02-27
CH672069A5 (ja) 1989-10-31
DK171392B1 (da) 1996-10-14
FI873727A0 (fi) 1987-08-27
JPS63152317A (ja) 1988-06-24
US4870090A (en) 1989-09-26
NO873571D0 (no) 1987-08-24
IT1211477B (it) 1989-11-03
AU7731187A (en) 1988-03-03
IT8767725A0 (it) 1987-08-21
SE8703308D0 (sv) 1987-08-26
DE3728499A1 (de) 1988-03-03
FI873727A (fi) 1988-02-28
FR2605222A1 (fr) 1988-04-22
SE8703308L (sv) 1988-02-28
GB2195532A (en) 1988-04-13
AU603375B2 (en) 1990-11-15
SG52393G (en) 1993-08-06
HK64993A (en) 1993-07-16
KR950002151B1 (ko) 1995-03-14
DK441987D0 (da) 1987-08-25
DK441987A (da) 1988-02-28
IE60601B1 (en) 1994-07-27
SE502323C2 (sv) 1995-10-02
NL8701994A (nl) 1988-03-16
GB2195532B (en) 1990-05-23
LU86973A1 (fr) 1987-12-16
GB8720219D0 (en) 1987-10-07

Similar Documents

Publication Publication Date Title
HUP0100815A2 (hu) Neurológiai és neuropszichiátriai rendellenességek kezelésére szolgáló gyógyszerkészítmények
PT87542A (pt) Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease
MY102016A (en) Thiazolidinedione derivatives, their production and use.
NO912410D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklen-derivater.
NO904839L (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
ES8801234A1 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxilicos.
NO180336C (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive kroman- og tiokromanderivater samt deres mellomprodukter
DE69327328T2 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
NO864443D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive n-substituerte 3-piperidin- eller 3-pyridin-karboksylsyrederivater.
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
ES538847A0 (es) Un derivado de fenilserina
NO873571L (no) Fremgangsmaate for fremstilling av et terapeutisk virksomtpreparat.
DK707988D0 (da) Fremgangsmaade til at haemme virus
ES552782A0 (es) Un procedimiento para preparar un compuesto de n-fenil-trans-4-guanidincometilciclohexanocarboxamida.
ATE131055T1 (de) Behandlung von kognitiven störungen.
ES552193A0 (es) Un procedimiento para la preparacion de nuevos peptidos.
FI891155A (fi) Menetelmä terapeuttisesti käyttökelpoisten 4,5,6,7-tetrahydroisotiatsolo/4,5-c/pyridiini-johdannaisten ja niiden isomeerien ja happoadditiosuolojen valmistamiseksi
NO167982C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive penemderivater.
NO152253C (no) Analogifremgangsmaate for fremstlling av 4-(n-(3`,4`-dihydroksybenzyliden)aminometyl)-cykloheksan-1-karboksylsyre med terapeutisk aktivitet
DE69429447T2 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
ATE95697T1 (de) Uricosuretische zusammensetzung.
GB2011887A (en) Antiallergic agent
ES468382A1 (es) Un procedimiento de preparacion de 6-ciclopropil-1,3-dihidro-1-metil-5-fenil-2-oxo-2h-tieno(2,3-e)diazepina